MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation
Open Access
- 4 December 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 16 (2), 179-190
- https://doi.org/10.1093/neuonc/not164
Abstract
Diffusely infiltrative growth of human astrocytic gliomas is one of the major obstacles to successful tumor therapy. Thorough insights into the molecules and pathways signaling glioma cell invasion thus appear of major relevance for the development of targeted and individualized therapies. By miRNA expression profiling of microdissected human tumor biopsy specimens we identified miR-328 as one of the main miRNAs upregulated in invading glioma cells in vivo and further investigated its role in glioma pathogenesis. We employed miRNA mimics and inhibitors to functionally characterize miR-328, 3′ untranslated region luciferase assays, and T-cell factor/lymphoid enhancer factor reporter assays to pinpoint miR-328 targets and signaling pathways, and analyzed miR-328 expression in a large panel of gliomas. First, we corroborated the invasion-promoting role of miR-328 in A172 and TP365MG glioma cells. Secreted Frizzled-related protein 1 (SFRP1), an inhibitor of Wnt signaling, was then pinpointed as a direct miR-328 target. SFRP1 expression is of prognostic relevance in gliomas with reduced expression, being associated with significantly lower overall patient survival in both the Repository of Molecular Brain Neoplasia Data (REMBRANDT) and The Cancer Genome Atlas. Of note, miR-328 regulated both SFRP1 protein expression levels and Wnt signaling pathway activity. Finally, in human glioma tissues miR-328 appeared to account for the downregulation of SFRP1 preferentially in lower-grade astrocytic gliomas and was inversely related to SFRP1 promoter hypermethylation. Taken together, we report on a novel molecular miR-328–dependent mechanism that via SFRP1 inhibition and Wnt activation contributes to the infiltrative glioma phenotype at already early stages of glioma progression, with unfavorable prognostic implications for the final outcome of the disease.Keywords
This publication has 46 references indexed in Scilit:
- Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patientsJournal of Translational Medicine, 2013
- Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion‐associated candidate genesNeuropathology and Applied Neurobiology, 2012
- miRNA expression profiling of lung adenocarcinomas: correlation with mutational statusLaboratory Investigation, 2010
- Downregulation of WIF-1 by hypermethylation in astrocytomasActa Biochimica et Biophysica Sinica, 2010
- WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growthBreast Cancer Research, 2009
- SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathwayGynecologic Oncology, 2009
- Astrocytic TumorsPublished by Springer Science and Business Media LLC ,2009
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007
- The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomasBritish Journal of Cancer, 2006
- Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cellsOncogene, 2000